Physician profile
Michael A Pritchett
NPI 1023055761
$1,321,746.93
in general payments reported to CMS, 2019-2025
69 companies · $112K in 2025
The $112K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99K · 2020: $169K · 2021: $282K · 2022: $340K · 2023: $125K · 2024: $195K · 2025: $112K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $281K · Consulting Fee: $63K · Travel and Lodging: $45K · Education: $32K · Food and Beverage: $12K · Gift: $43.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $280,805.00 |
| Consulting Fee | $63,297.50 |
| Travel and Lodging | $44,644.92 |
| Education | $31,678.99 |
| Food and Beverage | $11,759.02 |
| Gift | $43.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,037,708.87 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System, Ion |
| Astrazeneca Pharmaceuticals Lp | $47,804.36 | 2019-2025 | Tagrisso, Tezspire, Airsupra |
| Ambu A/S | $41,554.54 | 2020-2022 | |
| Actelion Pharmaceuticals US, INC. | $32,166.85 | 2019-2024 | Opsumit, Uptravi |
| Galvanize Therapeutics, INC | $30,388.66 | 2022-2025 | Aliya System |
| Ethicon Endo-Surgery INC. | $20,454.55 | 2019-2023 | |
| Covidien Lp | $17,019.85 | 2019-2020 | |
| Serpex Medical INC | $16,000.00 | 2024-2025 | |
| Ethicon INC. | $13,453.15 | 2019-2023 | Monarch Platform |
| United Therapeutics Corporation | $10,315.08 | 2019-2022 | |
| Medtronic, INC. | $9,735.63 | 2021-2024 | Illumisite |
| Pfizer INC. | $7,159.61 | 2020-2025 | |
| Ethicon US, LLC | $6,857.05 | 2019-2022 | |
| Healthmyne, INC. | $5,896.94 | 2019-2020 | |
| Medical Device Business Services, INC. | $5,342.20 | 2019 |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,520.35 | 2019-2022 | |
| Cook Incorporated | $4,377.50 | 2025 | Echotip Procore |
| Siemens Medical Solutions USA, INC. | $2,597.37 | 2024-2025 | Cios Spin |
| Philips North America LLC | $970.35 | 2019-2025 | (Bi2) Igt Systems Undivided, Azurion 7 M20, (9547) Igt Systems Undivided |
| Glaxosmithkline, LLC. | $830.47 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Noah Medical Corporation | $567.28 | 2023-2025 | Galaxy |
| Grifols USA, LLC | $517.46 | 2019-2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $465.50 | 2019-2025 | Keytruda, Winrevair, Keytruda Qlex |
| Takeda Pharmaceuticals U.S.A., INC. | $455.31 | 2019-2025 | Glassia, Iclusig, Fruzaqla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $379.60 | 2019-2024 | Ofev |
| Insmed, INC. | $331.34 | 2021-2025 | Arikayce |
| Mylan Specialty L.P. | $307.46 | 2019-2023 | Yupelri |
| Auris Health, INC. | $261.55 | 2019 | |
| Genzyme Corporation | $234.15 | 2019-2025 | |
| Amgen INC. | $223.35 | 2022-2025 | Tezspire, Tavneos, Lumakras |
| Genentech USA, INC. | $199.44 | 2019-2024 | Alecensa, Tecentriq, Rozlytrek |
| Pulmonx Corporation | $195.92 | 2021-2023 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Seagen INC. | $178.34 | 2021-2023 | Padcev, Tukysa |
| Regeneron Healthcare Solutions, INC. | $176.08 | 2019-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $175.38 | 2022-2025 | Acthar |
| Janssen Research & Development, LLC | $172.46 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $168.51 | 2020-2025 | |
| Servier Pharmaceuticals LLC | $156.27 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $131.61 | 2019-2023 | |
| Sunovion Pharmaceuticals INC. | $107.45 | 2019-2020 | |
| Olympus America INC. | $90.28 | 2019 | |
| Daiichi Sankyo INC. | $83.59 | 2019-2024 | Enhertu |
| Shire North American Group INC | $79.01 | 2019 | |
| Viatris Specialty LLC | $74.08 | 2025 | Yupelri |
| Celgene Corporation | $72.10 | 2019-2022 | |
| Lilly USA, LLC | $69.28 | 2019-2025 | Jaypirca, Retevmo, Verzenio |
| Ani Pharmaceuticals, INC. | $62.83 | 2025 | Purified Cortrophin Gel |
| Imbio INC. | $56.50 | 2023 | Imbio Lung Density Analysis |
| Eisai INC. | $56.08 | 2022-2024 | |
| Vifor Pharma, INC. | $49.18 | 2024-2025 | Zemaira |
| Cook Medical LLC | $41.76 | 2023 | Echotip Procore |
| Aveo Pharmaceuticals, INC. | $41.43 | 2024-2025 | |
| Advanced Respiratory, INC | $41.32 | 2021 | |
| Baxter Healthcare | $40.36 | 2022 | |
| Novartis Pharmaceuticals Corporation | $37.86 | 2019-2020 | |
| Csl Behring | $35.15 | 2019 | |
| Gilead Sciences, INC. | $34.30 | 2019-2021 | |
| Exelixis INC. | $34.27 | 2021-2024 | Cabometyx |
| Geron Corporation | $28.09 | 2025 | Rytelo |
| Beigene USA, INC. | $22.69 | 2023 | Brukinsa |
| Irhythm Technologies, INC. | $21.43 | 2024 | Zio Xt Patch, Zio Monitor |
| Abbott Laboratories | $21.41 | 2025 | Cardiomems |
| Verona Pharma, INC. | $18.41 | 2025 | Ohtuvayre |
| Janssen Biotech, INC. | $17.28 | 2025 | Rybrevant |
| Incyte Corporation | $16.74 | 2024 | Monjuvi |
| Veran Medical Technologies, INC. | $15.99 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $14.20 | 2024 | Lumryz |
| La Jolla Pharmaceutical Company | $13.47 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pritchett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.